STAT

STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized

STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorizedWorldPing

AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow digital health companies to release products without marketing authorization.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news